about
Indomethacin in controlling intracranial hypertension secondary to severe traumatic brain injuryEzetimibe for primary hypercholesterolemiaPositron emission tomography (PET) for the detection of vascular graft infectionsVitrification versus slow freezing for women undergoing oocyte cryopreservationDelivery arrangements for health systems in low-income countries: an overview of systematic reviewsImplementation strategies for health systems in low-income countries: an overview of systematic reviewsCombined therapy with statins and fibrates for people with dyslipidaemiaMini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI)Needle gauge and tip designs for preventing post-dural puncture headache (PDPH)Governance arrangements for health systems in low-income countries: an overview of systematic reviewsFinancial arrangements for health systems in low-income countries: an overview of systematic reviewsPosture and fluids for preventing post-dural puncture headacheIntravenous immunoglobulin to prevent relapses during pregnancy and postpartum in multiple sclerosisVitrification versus slow freezing for women undergoing oocyte cryopreservationCalcium supplementation for prevention of primary hypertensionInterventions for reducing medication errors in hospitalised adultsIntensity of continuous renal replacement therapy for acute kidney injuryTiming of continuous renal replacement therapy initiation for acute kidney injuryCognitive-behavioural interventions for attention deficit hyperactivity disorder (ADHD) in adultsFactor Xa inhibitors for acute coronary syndromesHigh versus low positive end-expiratory pressures (PEEP) levels for mechanically ventilated adult patients with acute lung injury and acute respiratory distress syndromePosture and fluids for preventing post-dural puncture headacheContinuous renal replacement modalities for acute kidney failure in critically ill patientsMicrofinance-based interventions for health outcomes in persons of low socio-economic statusProstanoids for critical limb ischaemiaInterferon Beta for Primary Progressive Multiple SclerosisEndometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytesPrescribed hypocaloric nutrition support for critically ill adultsInterferon Beta for Primary Progressive Multiple SclerosisContinuous renal replacement modalities for acute kidney failure in critically ill patientsEndometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytesCombined therapy with statins and fibrates for people with dyslipidaemiaXa inhibitors for acute coronary syndromesEzetimibe for primary hypercholesterolemiaHomocysteine lowering interventions for preventing cardiovascular eventsTrimetazidine for stable anginaProstanoids for critical limb ischemiaCalcium supplementation for weight reduction in overweight or obese peopleInter-pregnancy interval and risk of recurrent pre-eclampsia: systematic review and meta-analysisCourse of Chronic Trypanosoma cruzi Infection after Treatment Based on Parasitological and Serological Tests: A Systematic Review of Follow-Up Studies
P50
Q24187651-F9C88676-25FB-4E69-B22D-53285029CD18Q24187681-F0D4EAC8-3906-4AEF-91D6-6586D88F2C1FQ24188131-10174C2A-B8A6-4C22-A95B-950C5A23AC84Q24193770-8C63A8A6-B003-407E-8EAE-9DC19249C743Q24194923-93AC7542-64BE-4645-8A79-C1901E6BFA83Q24194927-0E4F0BF3-8572-462D-BFCE-62E9FDB58852Q24195172-6FB26880-61F3-47EE-9E6D-061A3DCE8466Q24197659-08FC9E38-F5A7-40DC-A126-9DF6A3DD8F23Q24197718-6192CFE1-F3A6-4EBA-8250-3B017748B080Q24197731-BB5F9FD4-D290-4CE5-B2CA-0EB92539B963Q24197740-3F1C259B-1997-44FD-B78B-E6CB2A969A65Q24201239-E1F66BD6-DEA6-4C4D-BD06-BFEDC9BE32F4Q24201599-6A6A8972-E548-4A50-BD3A-E8BF055B0463Q24201780-4E89CAA0-AF66-452E-A8A4-070B269B27E8Q24201840-8F856FD3-A4B7-4582-A3E6-D137B83C3F0EQ24202278-EE1EA655-6CFF-4695-AD64-F521F0D5BAA2Q24202392-3262D575-C32B-41AC-BA8B-242E131AEC42Q24202413-60F70FF7-261C-4BDF-94B7-367DA3646C64Q24202650-497B0E56-71B8-49BB-9250-2A663D66E2D2Q24234760-0DFB26F0-397D-42E8-AB45-1A5F2B19E797Q24235011-6C993172-5B72-4D2B-B7A5-3BCD77DDA9F5Q24235894-81EC9BBE-EF69-4E53-A7D9-B2E5996E761FQ24236142-26EB421E-D036-46B9-A91B-C99750186259Q24236607-504A85D8-AD3E-44EE-AEE0-05FAA42F4A5EQ24240537-DE4A78E9-C9E2-427E-89C2-E4C8431ED168Q24240620-EF8AE7E2-DFCE-41D7-A71F-C0BDA4C6391AQ24240694-1FEEA5C9-CC42-4422-9BC8-C938A1CCEDA8Q24240861-9719915E-12C1-4D85-B840-71DFD0EE71AAQ24241541-DCA8D6D5-8A8A-4C04-AB4D-33563142F0EBQ24242127-32EBCB98-ACF8-4F5E-81DE-767DFCC3F3E4Q24243680-305DCBF5-D182-48F9-8BA8-3F14250C1B5EQ24243737-550C8A17-9FCE-4B51-8940-2AAB75DD18DCQ24243766-1594BED4-04C9-441B-BAD3-523C1894A8C5Q24244704-60D9DB15-4C69-4728-9DCD-72D3E5DD5DE9Q24244823-3E059303-6C9F-4929-A2FE-54B6AD07E0DBQ24245946-A79221FA-6A56-419C-9737-57EF4CD92BD7Q24246007-0B03088D-70E6-454F-A0DC-7C7B48C4F7E1Q26471306-2064080D-3881-4F19-8DA9-BD10F9BF4C40Q26739300-8C8BE12B-85BC-41D4-9DDF-AF651E34E5ECQ26782118-55B3CAB6-EE83-4096-A3AD-F39B4E8B5E8C
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Agustín Ciapponi
@ast
Agustín Ciapponi
@en
Agustín Ciapponi
@es
type
label
Agustín Ciapponi
@ast
Agustín Ciapponi
@en
Agustín Ciapponi
@es
prefLabel
Agustín Ciapponi
@ast
Agustín Ciapponi
@en
Agustín Ciapponi
@es